Even though Novo Nordisk's GLP-1 failed in Alzheimer's trial, some researchers are cautiously optimistic that obesity and diabetes drugs may have benefits for people with one of the most common forms ...

Vascular dementia: a debilitating neurodegenerative disorder that has no effective treatment Currently there are no effective treatments of vascular dementia, a condition in which a compromise of ...

Popular diabetes and weight loss drug, semaglutide- the active ingredient in 'Wegovy' and 'Ozempic'- may lower dementia risk in people with type 2 diabetes. The corresponding study was published in ...

There has been a lot of chatter over the past year about the positive impacts of diabetes medications—like Ozempic—on a slew of serious health conditions. Now, there’s a new type of prescription ...

The factors that raise the risk of heart disease and stroke can also raise the risk of dementia. When blood vessels are damaged or blocked, it can deprive your brain of vital oxygen and nutrients, and ...

A psychologist has delved into some common queries about vascular dementia, which accounts for roughly 5 to 10% of cases. This type of cognitive decline is often mistaken for Alzheimer's and other ...

Add Yahoo as a preferred source to see more of our stories on Google. ozempic type pen Medications designed to treat diabetes by lowering blood sugar levels, like Ozempic, continue to turn up added ...

Obesity has long been linked to a higher risk of vascular-related dementia, a progressive brain disease that causes nerve cell damage. However, it has been unclear, until now, whether excess weight ...

Dementia prevention is a critical area of research, as experts want to understand what people can do to decrease dementia risk. A recent study found that more than 5 years of taking medications like ...

There’s rarely good news about Alzheimer’s disease, but a failed study may open the door to more research about vascular dementia. Novo Nordisk NVO announced Monday that its oral GLP-1 called Rybelsus ...